To use all functions of this page, please activate cookies in your browser.
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Metopon
Metopon (5-methylhydromorphone hydrochloride) is an opiate analogue that is a methylated derivative of hydromorphone which was invented in 1948 as an analgesic. [1] Product highlightMetopon is sometimes used in medicine, but although longer acting than hydromorphone, metopon is less potent and has poor oral bioavailability, so generally has few advantages to distinguish it from other, more commonly used opioid analgesics. [2] It has similar side effects to other opiates, which include itching, nausea and respiratory depression.
References
|
||||||||||||||||||||||||||||||||||||||||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Metopon". A list of authors is available in Wikipedia. |
- Category:Neurotransmitters
- Genomics_Institute_of_the_Novartis_Research_Foundation
- Change of date: POWTECH to be held from 27 to 29 September 2022 - Parallel with FACHPACK
- Lawsone
- Lurgi to manage Technology Coordination for Hydrocracker - Lurgi is responsible for technology coordination for hydrocracker and downstream process unit in the Russian refinery TAIF-NK